At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.
作者信息
Martinez Fernando J, Han MeiLan K, Allinson James P, Barr R Graham, Boucher Richard C, Calverley Peter M A, Celli Bartolome R, Christenson Stephanie A, Crystal Ronald G, Fagerås Malin, Freeman Christine M, Groenke Lars, Hoffman Eric A, Kesimer Mehmet, Kostikas Kostantinos, Paine Robert, Rafii Shahin, Rennard Stephen I, Segal Leopoldo N, Shaykhiev Renat, Stevenson Christopher, Tal-Singer Ruth, Vestbo Jørgen, Woodruff Prescott G, Curtis Jeffrey L, Wedzicha Jadwiga A
机构信息
1 Weill Cornell Medical College, New York, New York.
2 University of Michigan School of Medicine, Ann Arbor, Michigan.
出版信息
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1540-1551. doi: 10.1164/rccm.201710-2028PP.
Abstract
摘要
相似文献
1
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.根源：定义并阻止早期慢性阻塞性肺疾病的进展
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1540-1551. doi: 10.1164/rccm.201710-2028PP.
2
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.慢性阻塞性肺疾病的当前争议。慢性阻塞性肺疾病全球倡议科学委员会的报告。
Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS.
3
Spirometric Classifications of Chronic Obstructive Pulmonary Disease Severity as Predictive Markers for Clinical Outcomes: The HUNT Study.慢性阻塞性肺疾病严重程度的肺量计分类作为临床结局的预测指标：HUNT研究
Am J Respir Crit Care Med. 2021 Apr 15;203(8):1033-1037. doi: 10.1164/rccm.202011-4174LE.
4
Diagnosing chronic obstructive pulmonary disease.诊断慢性阻塞性肺疾病。
BMJ. 2015 Nov 24;351:h6171. doi: 10.1136/bmj.h6171.
5
[Chronic obstructive pulmonary disease: new guidelines].[慢性阻塞性肺疾病：新指南]
MMW Fortschr Med. 2012 Nov 29;154(21):75-6. doi: 10.1007/s15006-012-1605-y.
6
Outpatient management of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的门诊管理
Clin Med (Lond). 2004 May-Jun;4(3):220-4. doi: 10.7861/clinmedicine.4-3-220.
7
What happens between first symptoms and first acute exacerbation of COPD - observational study of routine data and patient survey.COPD 首次症状与首次急性加重之间的情况 - 常规数据和患者调查的观察性研究。
Health Soc Care Deliv Res. 2024 Oct;12(43):1-80. doi: 10.3310/CGTR6370.
8
Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病全球倡议2017年慢性阻塞性肺疾病分类与肺功能下降
Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE.
9
COPD hits "The Wall".慢性阻塞性肺疾病遭遇“瓶颈”。
COPD. 2013 Feb;10(1):1-3. doi: 10.3109/15412555.2013.758442. Epub 2013 Jan 16.
10
Year in review 2016: Chronic obstructive pulmonary disease and asthma.2016年回顾：慢性阻塞性肺疾病与哮喘
Respirology. 2017 May;22(4):820-828. doi: 10.1111/resp.13037. Epub 2017 Mar 28.
引用本文的文献
1
Cross-Sectional Survey of COPD Risk in Undiagnosed Adults in Saudi Arabia Using the Arabic COPD-PS.使用阿拉伯语慢性阻塞性肺疾病预测筛查工具对沙特阿拉伯未确诊成年人慢性阻塞性肺疾病风险的横断面调查
Int J Chron Obstruct Pulmon Dis. 2025 Aug 20;20:2905-2911. doi: 10.2147/COPD.S530064. eCollection 2025.
2
Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review.超越吸烟：慢性阻塞性肺疾病的新兴驱动因素及其在低收入和中等收入国家的临床意义：一项叙述性综述
J Clin Med. 2025 Jun 30;14(13):4633. doi: 10.3390/jcm14134633.
3
The Impact of Gut Microbiota on Chronic Obstructive Pulmonary Disease: A Dual-Sample Mendelian Randomization Study.肠道微生物群对慢性阻塞性肺疾病的影响：一项双样本孟德尔随机化研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 17;20:1983-1993. doi: 10.2147/COPD.S511383. eCollection 2025.
4
Glycopyrrolate/formoterol fumarate MDI in mild-to-moderate chronic obstructive pulmonary disease (PIONEER): a protocol for a randomised, double-blind, placebo-controlled trial.格隆溴铵/富马酸福莫特罗定量吸入气雾剂用于轻至中度慢性阻塞性肺疾病（先锋研究）：一项随机、双盲、安慰剂对照试验方案
BMJ Open Respir Res. 2025 Jun 15;12(1):e002656. doi: 10.1136/bmjresp-2024-002656.
5
All-cause and cause-specific mortality in individuals with COPD in China: a 16-year follow-up cohort study.中国慢性阻塞性肺疾病患者的全因死亡率和特定病因死亡率：一项16年随访队列研究。
Eur J Epidemiol. 2025 Jun 4. doi: 10.1007/s10654-025-01252-7.
6
Definitions of early COPD and markers and tools for predicting progression: a systematic review protocol.早期慢性阻塞性肺疾病的定义以及预测疾病进展的标志物和工具：一项系统评价方案
BMJ Open. 2025 Jun 3;15(6):e100032. doi: 10.1136/bmjopen-2025-100032.
7
Multi-omics characterization of early chronic obstructive pulmonary disease.早期慢性阻塞性肺疾病的多组学特征分析
Respir Res. 2025 Apr 28;26(1):167. doi: 10.1186/s12931-025-03250-5.
8
Association between oxidative balance score and lung function and FeNO and mortality in the US population.美国人群中氧化平衡评分与肺功能、呼出一氧化氮（FeNO）及死亡率之间的关联。
BMC Pulm Med. 2025 Apr 8;25(1):164. doi: 10.1186/s12890-025-03626-9.
9
Assessment of Muscular Strength and Functional Capacity in Smoker Population Without Any Diagnosed Respiratory Disease: A Cross-Sectional Study.无任何确诊呼吸系统疾病的吸烟人群肌肉力量和功能能力评估：一项横断面研究。
Healthcare (Basel). 2025 Feb 24;13(5):493. doi: 10.3390/healthcare13050493.
10
Contrasting the clinical and biological characteristics of young and old COPD patients.对比年轻和老年慢性阻塞性肺疾病（COPD）患者的临床和生物学特征。
ERJ Open Res. 2025 Feb 25;11(1). doi: 10.1183/23120541.00671-2024. eCollection 2025 Jan.
本文引用的文献
1
Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.基于人群研究的 CT 气道总计数与慢性阻塞性肺疾病进展风险。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):56-65. doi: 10.1164/rccm.201704-0692OC.
2
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.噻托溴铵治疗早期慢性阻塞性肺疾病。
N Engl J Med. 2017 Sep 7;377(10):923-935. doi: 10.1056/NEJMoa1700228.
3
Airway Mucin Concentration as a Marker of Chronic Bronchitis.气道黏液浓度作为慢性支气管炎的一个标志物
N Engl J Med. 2017 Sep 7;377(10):911-922. doi: 10.1056/NEJMoa1701632.
4
Protected sampling is preferable in bronchoscopic studies of the airway microbiome.在气道微生物群的支气管镜检查研究中，采用保护性采样更为可取。
ERJ Open Res. 2017 Aug 30;3(3). doi: 10.1183/23120541.00019-2017. eCollection 2017 Jul.
5
Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.慢性阻塞性肺疾病（COPD）高危个体的评估：超越慢性阻塞性肺疾病全球倡议的范畴
Chronic Obstr Pulm Dis. 2016 Jun 28;3(3):653-667. doi: 10.15326/jcopdf.3.3.2016.0129.
6
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.糠酸氟替卡松、维兰特罗与伴有较高心血管风险的中度慢性阻塞性肺疾病患者的肺功能下降。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):47-55. doi: 10.1164/rccm.201610-2086OC.
7
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.慢性阻塞性肺疾病患者的加重频率：SPIROMICS 队列分析。
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
8
The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.胸部计算机断层扫描在慢性阻塞性肺疾病患者评估与管理中的作用
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1372-1379. doi: 10.1164/rccm.201703-0451PP.
9
Multiple biomarkers predict disease severity, progression and mortality in COPD.多种生物标志物可预测慢性阻塞性肺疾病（COPD）的疾病严重程度、进展及死亡率。
Respir Res. 2017 Jun 13;18(1):117. doi: 10.1186/s12931-017-0597-7.
10
Update in Chronic Obstructive Pulmonary Disease 2016.2016年慢性阻塞性肺疾病的进展
Am J Respir Crit Care Med. 2017 Aug 15;196(4):414-424. doi: 10.1164/rccm.201703-0588UP.
Zotero 插件